$SCWO
374Water Inc

2023 Q3 Form 10-Q Financial Statement

#000165495423010302 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $12.29K $49.86K $1.031M
YoY Change -98.67% -95.16% 6958.41%
Cost Of Revenue $178.7K $45.26K $902.5K
YoY Change -78.01% -94.99%
Gross Profit -$166.4K $4.606K $128.0K
YoY Change -250.81% -96.4% 776.85%
Gross Profit Margin -1353.86% 9.24% 12.42%
Selling, General & Admin $1.400M $1.502M $920.2K
YoY Change 54.68% 63.2% 152.31%
% of Gross Profit 32603.99% 718.8%
Research & Development $317.6K $272.0K $422.7K
YoY Change 168.55% -35.66% 239.04%
% of Gross Profit 5904.56% 330.18%
Depreciation & Amortization $20.00K $15.17K $16.71K
YoY Change 2976.92% -9.22% 5867.86%
% of Gross Profit 329.35% 13.05%
Operating Expenses $1.716M $1.774M $1.343M
YoY Change 67.69% 32.08% -28.92%
Operating Profit -$1.882M -$1.769M -$1.215M
YoY Change 106.18% 45.62% -35.19%
Interest Expense $150.0K $74.97K $610.00
YoY Change 93650.0% 12190.16% 90.63%
% of Operating Profit
Other Income/Expense, Net $151.0K $118.5K $613.00
YoY Change 93080.86% 19234.42% 89.78%
Pretax Income -$1.731M -$1.651M -$1.214M
YoY Change 89.68% 35.93% -35.21%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.731M -$1.651M -$1.214M
YoY Change 89.68% 35.93% -35.21%
Net Earnings / Revenue -14088.13% -3310.22% -117.83%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 -$0.01 -$9.585K
COMMON SHARES
Basic Shares Outstanding 132.7M shares 129.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.80M $14.60M $10.09M
YoY Change 52.34% 44.72% 60.26%
Cash & Equivalents $12.80M $14.60M $3.132M
Short-Term Investments $0.00 $0.00 $6.988M
Other Short-Term Assets $420.0K $206.5K $527.7K
YoY Change -67.64% -60.88% 3506.97%
Inventory $1.910M $1.804M
Prepaid Expenses $416.5K $206.5K $527.7K
Receivables $16.76K $17.53K $242.8K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.84M $18.34M $10.86M
YoY Change 70.74% 68.87% 71.89%
LONG-TERM ASSETS
Property, Plant & Equipment $182.1K $140.0K $6.843K
YoY Change 46.16% 1945.37% 418.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $34.36K
YoY Change 70.95%
Total Long-Term Assets $1.187M $1.162M $1.038M
YoY Change 4.08% 11.95% -5.22%
TOTAL ASSETS
Total Short-Term Assets $16.84M $18.34M $10.86M
Total Long-Term Assets $1.187M $1.162M $1.038M
Total Assets $18.03M $19.50M $11.90M
YoY Change 63.83% 63.9% 60.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $380.0K $334.2K $682.6K
YoY Change -63.59% -51.04% 339.08%
Accrued Expenses
YoY Change
Deferred Revenue $183.1K $183.1K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $565.1K $517.3K $1.432M
YoY Change -55.23% -63.88% 718.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $565.1K $517.3K $1.432M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $565.1K $517.3K $1.432M
YoY Change -55.23% -63.88% 718.34%
SHAREHOLDERS EQUITY
Retained Earnings -$12.87M -$11.14M -$5.247M
YoY Change 108.97% 112.32% 170.99%
Common Stock $13.27K $13.07K $12.67K
YoY Change 4.73% 3.16% -98.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.46M $18.98M $10.46M
YoY Change
Total Liabilities & Shareholders Equity $18.03M $19.50M $11.90M
YoY Change 63.83% 63.9% 60.5%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$1.731M -$1.651M -$1.214M
YoY Change 89.68% 35.93% -35.21%
Depreciation, Depletion And Amortization $20.00K $15.17K $16.71K
YoY Change 2976.92% -9.22% 5867.86%
Cash From Operating Activities -$1.820M -$1.699M -$1.140M
YoY Change 15.6% 49.04% 141.3%
INVESTING ACTIVITIES
Capital Expenditures $50.00K $2.920K -$3.320K
YoY Change -142.23% -187.95% 178.99%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$7.000M
YoY Change -100.0% -100.0% -72194.95%
Cash From Investing Activities -$50.00K -$2.920K -$7.004M
YoY Change -105.67% -99.96% -82303.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 70.00K 7.148M 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.820M -1.699M -1.140M
Cash From Investing Activities -50.00K -2.920K -7.004M
Cash From Financing Activities 70.00K 7.148M 0.000
Net Change In Cash -1.800M 5.446M -8.143M
YoY Change 159.95% -166.88% -230.85%
FREE CASH FLOW
Cash From Operating Activities -$1.820M -$1.699M -$1.140M
Capital Expenditures $50.00K $2.920K -$3.320K
Free Cash Flow -$1.870M -$1.701M -$1.136M
YoY Change 28.43% 49.74% 141.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
399448 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1451881 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9916831 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
11551783 usd
dei Entity Central Index Key
EntityCentralIndexKey
0000933972
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
130679012 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126702545 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.50
CY2023Q1 scwo Weighted Average Remaining Contractual Life Years Ending Balance
WeightedAverageRemainingContractualLifeYearsEndingBalance
P1Y8M19D
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-27866
dei Entity Registrant Name
EntityRegistrantName
374WATER INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-0271109
dei Entity Address Address Line1
EntityAddressAddressLine1
701 W Main Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 410
dei Entity Address City Or Town
EntityAddressCityOrTown
Durham
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27701
dei City Area Code
CityAreaCode
919
dei Local Phone Number
LocalPhoneNumber
888-8194
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001
dei Trading Symbol
TradingSymbol
SCWO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
132667107 shares
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14599361 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4046937 usd
CY2023Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1709027 usd
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
918164 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1804495 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1660710 usd
CY2023Q2 us-gaap Investments
Investments
0 usd
CY2022Q4 us-gaap Investments
Investments
1944464 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
206453 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
153455 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
18336862 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
8723730 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
139965 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
143079 usd
CY2023Q2 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
1021781 usd
CY2022Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
1050022 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1161746 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1193101 usd
CY2023Q2 us-gaap Assets
Assets
19498608 usd
CY2022Q4 us-gaap Assets
Assets
9916831 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
334229 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1449582 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
183061 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
200109 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13528 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
517290 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1663219 usd
CY2023Q2 us-gaap Liabilities
Liabilities
517290 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1663219 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
13067 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12669 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30103715 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16110221 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11140902 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7849982 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5438 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19296 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
18981318 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8253612 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19498608 usd
CY2023Q2 us-gaap Revenues
Revenues
49863 usd
CY2022Q2 us-gaap Revenues
Revenues
1030528 usd
us-gaap Revenues
Revenues
851321 usd
us-gaap Revenues
Revenues
1303759 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45257 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
902508 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
765403 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1150494 usd
us-gaap Gross Profit
GrossProfit
85918 usd
us-gaap Gross Profit
GrossProfit
153265 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
271964 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
422695 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
627869 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
608348 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
733121 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
700683 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
92285 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
141104 usd
us-gaap Professional Fees
ProfessionalFees
191857 usd
us-gaap Professional Fees
ProfessionalFees
291760 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
676333 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
379661 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1261995 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
641067 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1773703 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1342908 usd
us-gaap Operating Expenses
OperatingExpenses
3533602 usd
us-gaap Operating Expenses
OperatingExpenses
2241858 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1769097 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1214888 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3447684 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2088593 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
74967 usd
CY2022Q2 us-gaap Interest Income Other
InterestIncomeOther
613 usd
us-gaap Interest Income Other
InterestIncomeOther
112826 usd
us-gaap Interest Income Other
InterestIncomeOther
1453 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
43553 usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
43938 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
7 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
118520 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
613 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
156764 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1460 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1650577 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1214275 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3290920 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2087133 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1650577 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1214275 usd
us-gaap Net Income Loss
NetIncomeLoss
-3290920 usd
us-gaap Net Income Loss
NetIncomeLoss
-2087133 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4943 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-771 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5438 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-771 usd
CY2023Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 usd
CY2022Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-11243 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-11243 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4943 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12014 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5438 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12014 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1645634 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1226289 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3285482 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2099147 usd
CY2023Q2 scwo Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.01
CY2022Q2 scwo Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.01
scwo Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.03
scwo Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.02
CY2023Q2 scwo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
129389098 shares
CY2022Q2 scwo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
126680895 shares
scwo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
128274091 shares
scwo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
126591017 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8253612 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8294708 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
214924 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
824 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
18967 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1640343 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
15142692 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5146730 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
71200 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18 usd
CY2023Q2 scwo Exercise Of Warrants Amount
ExerciseOfWarrantsAmount
37500 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
228812 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
4943 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1650577 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
18981318 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
12327085 usd
CY2022Q1 scwo Conversion Of Preferred Shares To Common Shares Amount
ConversionOfPreferredSharesToCommonSharesAmount
-2 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
97558 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-872858 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
138912 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-771 usd
CY2022Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-11243 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1214275 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10464406 usd
us-gaap Profit Loss
ProfitLoss
3290920 usd
us-gaap Profit Loss
ProfitLoss
2087133 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
44281 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
33174 usd
us-gaap Share Based Compensation
ShareBasedCompensation
514934 usd
us-gaap Share Based Compensation
ShareBasedCompensation
236470 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
5767 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17526 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
242816 usd
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
790863 usd
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
143785 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
52998 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
309234 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1115353 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
619652 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-17048 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
732620 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-13528 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-6465 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4877039 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1023731 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
6999927 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7303 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6608 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
5623 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
494 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12926 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7007029 usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
1963430 usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13478959 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15442389 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
10552424 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8030760 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4046937 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11131175 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14599361 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3100415 usd
scwo Conversion Of Preferred Stock To Common Stock
ConversionOfPreferredStockToCommonStock
0 usd
scwo Conversion Of Preferred Stock To Common Stock
ConversionOfPreferredStockToCommonStock
133 usd
CY2023Q2 us-gaap Cash
Cash
13202816 usd
CY2022Q4 us-gaap Cash
Cash
1182412 usd
CY2023Q2 scwo Investments Adjusted Cost
InvestmentsAdjustedCost
14599361 usd
CY2023Q2 scwo Unrealized Loss
UnrealizedLoss
0 usd
CY2023Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
14599361 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14599361 usd
CY2023Q2 scwo Marketables Securities Current
MarketablesSecuritiesCurrent
0 usd
CY2023Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
0 usd
CY2022Q4 scwo Investments Adjusted Cost
InvestmentsAdjustedCost
6010369 usd
CY2022Q4 scwo Unrealized Loss
UnrealizedLoss
18968 usd
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
5991401 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4046937 usd
CY2022Q4 scwo Marketables Securities Current
MarketablesSecuritiesCurrent
1944464 usd
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
0 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
406 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
scwo Accounts And Receivable Allowance For Credit Loss
AccountsAndReceivableAllowanceForCreditLoss
0 usd
CY2022 scwo Accounts And Receivable Allowance For Credit Loss
AccountsAndReceivableAllowanceForCreditLoss
0 usd
scwo Accounts Receivable Allowance For Credit Losses Current Period Provision
AccountsReceivableAllowanceForCreditLossesCurrentPeriodProvision
406 usd
CY2022 scwo Accounts Receivable Allowance For Credit Losses Current Period Provision
AccountsReceivableAllowanceForCreditLossesCurrentPeriodProvision
0 usd
us-gaap Proceeds Accounts Receivable Previously Written Off Recovery
ProceedsAccountsReceivablePreviouslyWrittenOffRecovery
0 usd
CY2022 us-gaap Proceeds Accounts Receivable Previously Written Off Recovery
ProceedsAccountsReceivablePreviouslyWrittenOffRecovery
0 usd
scwo Accounts And Financing Receivables Allowance For Credit Loss
AccountsAndFinancingReceivablesAllowanceForCreditLoss
406 usd
CY2022 scwo Accounts And Financing Receivables Allowance For Credit Loss
AccountsAndFinancingReceivablesAllowanceForCreditLoss
0 usd
us-gaap Depreciation
Depreciation
10417 usd
us-gaap Depreciation
Depreciation
728 usd
scwo Revenues From Sales
RevenuesFromSales
843321 usd
scwo Revenues From Sale Of Treatability Services
RevenuesFromSaleOfTreatabilityServices
8000 usd
scwo Revenues From Sales
RevenuesFromSales
1303759 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
627869 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
608348 usd
CY2023Q2 us-gaap Capital
Capital
17819572 usd
CY2022Q4 us-gaap Capital
Capital
7060511 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11140902 usd
scwo Net Income Loss1
NetIncomeLoss1
3290920 usd
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
4877039 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
396115 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
755218 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1408380 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
905492 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1804495 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1660710 usd
CY2022 scwo Billings Deferred Unearned Revenue
BillingsDeferredUnearnedRevenue
1467189 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1050022 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
5623 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33864 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1021781 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1062856 usd
CY2022 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
52292 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
65126 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1050022 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33864 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33174 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
33967 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
67933 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
67933 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
67933 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
67933 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
716082 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1021781 usd
scwo Revenue Percentage
RevenuePercentage
1 pure
us-gaap Revenues
Revenues
851321 usd
scwo Revenue Percentage
RevenuePercentage
1 pure
us-gaap Revenues
Revenues
1303759 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
200109 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
scwo Billings Deferred Unearned Revenue
BillingsDeferredUnearnedRevenue
21190 usd
scwo Recognition Of Prior Unearned Revenue
RecognitionOfPriorUnearnedRevenue
-38238 usd
CY2022 scwo Recognition Of Prior Unearned Revenue
RecognitionOfPriorUnearnedRevenue
-1267080 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
183061 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
200109 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
918164 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
scwo Services Performed But Unbilled
ServicesPerformedButUnbilled
790863 usd
CY2022 scwo Services Performed But Unbilled
ServicesPerformedButUnbilled
918164 usd
scwo Services Billed
ServicesBilled
0 usd
CY2022 scwo Services Billed
ServicesBilled
0 usd
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
1709027 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
918164 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 scwo Blank Check Preferred Stock
BlankCheckPreferredStock
50000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
130679012 shares
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2342261 usd
CY2023Q2 scwo Warrants Outstanding Series One Shares
WarrantsOutstandingSeriesOneShares
1235000 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.50
CY2023Q2 scwo Price Of Market
PriceOfMarket
2.39
CY2023Q1 scwo Exercised Under Existing Warrants Shares Of Common Stock
ExercisedUnderExistingWarrantsSharesOfCommonStock
15000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1235000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1250000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.50
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
450000 usd
CY2023Q1 scwo Weighted Average Remaining Contractual Life Years Beginning Balance
WeightedAverageRemainingContractualLifeYearsBeginningBalance
P1Y11M15D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2023Q1 scwo Weighted Average Exercise Price Exercised
WeightedAverageExercisePriceExercised
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1250000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.50
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2775000 usd
CY2023Q2 scwo Weighted Average Remaining Contractual Life Years Beginning Balance
WeightedAverageRemainingContractualLifeYearsBeginningBalance
P1Y8M19D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
15000 shares
CY2023Q2 scwo Weighted Average Exercise Price Exercised
WeightedAverageExercisePriceExercised
2.50
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1235000 shares
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.50
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q2 scwo Weighted Average Remaining Contractual Life Years Ending Balance
WeightedAverageRemainingContractualLifeYearsEndingBalance
P1Y5M19D
scwo Stock In Excess Percentage Of Outstanding Share
StockInExcessPercentageOfOutstandingShare
0.05 pure
scwo Related Party Transaction Expenses From Transactions With Related Parties
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParties
599571 usd
scwo Related Parties Cost
RelatedPartiesCost
29293 usd

Files In Submission

Name View Source Status
0001654954-23-010302-index-headers.html Edgar Link pending
0001654954-23-010302-index.html Edgar Link pending
0001654954-23-010302.txt Edgar Link pending
0001654954-23-010302-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scwo-20230630.xsd Edgar Link pending
scwo_10q.htm Edgar Link pending
scwo_ex311.htm Edgar Link pending
scwo_ex312.htm Edgar Link pending
scwo_ex321.htm Edgar Link pending
scwo_ex322.htm Edgar Link pending
Show.js Edgar Link pending
scwo-20230630_def.xml Edgar Link unprocessable
scwo_10q_htm.xml Edgar Link completed
scwo-20230630_lab.xml Edgar Link unprocessable
scwo-20230630_cal.xml Edgar Link unprocessable
scwo-20230630_pre.xml Edgar Link unprocessable